KZA 0.00% 8.0¢ kazia therapeutics limited

Announcement out from a US conference given on Friday.The Yale...

  1. 1,154 Posts.
    Announcement out from a US conference given on Friday.

    The Yale researchers reported that 74 percent of patients with late-stage, platinum-resistant tumors who received the phenoxodiol and cisplatin combination showed evidence of a change in tumor growth by way of either tumor shrinkage or no increase in tumor size.


    G
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.